ATE328082T1 - Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen - Google Patents
Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungenInfo
- Publication number
- ATE328082T1 ATE328082T1 AT01967422T AT01967422T ATE328082T1 AT E328082 T1 ATE328082 T1 AT E328082T1 AT 01967422 T AT01967422 T AT 01967422T AT 01967422 T AT01967422 T AT 01967422T AT E328082 T1 ATE328082 T1 AT E328082T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnostic
- shortened
- therapeutic applications
- bard1 protein
- bard1
- Prior art date
Links
- 101700002522 BARD1 Proteins 0.000 title abstract 2
- 102100028048 BRCA1-associated RING domain protein 1 Human genes 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0011207A FR2813606B1 (fr) | 2000-09-01 | 2000-09-01 | Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE328082T1 true ATE328082T1 (de) | 2006-06-15 |
Family
ID=8853916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01967422T ATE328082T1 (de) | 2000-09-01 | 2001-09-03 | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7566764B2 (https=) |
| EP (1) | EP1313855B1 (https=) |
| JP (1) | JP4995399B2 (https=) |
| AT (1) | ATE328082T1 (https=) |
| CA (1) | CA2421258C (https=) |
| DE (1) | DE60120187T2 (https=) |
| FR (1) | FR2813606B1 (https=) |
| WO (1) | WO2002018536A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2681360A1 (en) * | 2007-04-02 | 2008-10-09 | Universite De Geneve | Deletion bearing bard1 isoforms and use thereof |
| SG10201506437PA (en) * | 2010-08-17 | 2015-10-29 | Univ Geneve | BARD1 Isoforms in Lung and Colorectal Cancer and Use Thereof |
| CN105765386B (zh) | 2013-10-31 | 2019-07-16 | 瑞泽恩制药公司 | 用于检测中和抗体的竞争性配体结合测定法 |
| EP2871480A1 (en) * | 2013-11-06 | 2015-05-13 | Bard1Ag SA | Lung Cancer Diagnosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998012327A2 (en) * | 1996-09-20 | 1998-03-26 | Board Of Regents, The University Of Texas System | Compositions and methods comprising bard1 and other brca1 binding proteins |
| US6342219B1 (en) * | 1999-04-28 | 2002-01-29 | Board Of Regents, The University Of Texas System | Antibody compositions for selectively inhibiting VEGF |
-
2000
- 2000-09-01 FR FR0011207A patent/FR2813606B1/fr not_active Expired - Fee Related
-
2001
- 2001-09-03 US US10/363,285 patent/US7566764B2/en not_active Expired - Lifetime
- 2001-09-03 EP EP01967422A patent/EP1313855B1/fr not_active Expired - Lifetime
- 2001-09-03 WO PCT/FR2001/002731 patent/WO2002018536A2/fr not_active Ceased
- 2001-09-03 AT AT01967422T patent/ATE328082T1/de active
- 2001-09-03 CA CA2421258A patent/CA2421258C/fr not_active Expired - Fee Related
- 2001-09-03 DE DE60120187T patent/DE60120187T2/de not_active Expired - Lifetime
- 2001-09-03 JP JP2002524039A patent/JP4995399B2/ja not_active Expired - Fee Related
-
2009
- 2009-06-23 US US12/489,893 patent/US20100016228A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2421258C (fr) | 2011-04-19 |
| WO2002018536A3 (fr) | 2003-01-03 |
| DE60120187D1 (de) | 2006-07-06 |
| JP4995399B2 (ja) | 2012-08-08 |
| US20040234959A1 (en) | 2004-11-25 |
| FR2813606A1 (fr) | 2002-03-08 |
| FR2813606B1 (fr) | 2004-04-30 |
| EP1313855B1 (fr) | 2006-05-31 |
| US20100016228A1 (en) | 2010-01-21 |
| EP1313855A2 (fr) | 2003-05-28 |
| JP2004518410A (ja) | 2004-06-24 |
| DE60120187T2 (de) | 2007-03-29 |
| WO2002018536A2 (fr) | 2002-03-07 |
| CA2421258A1 (fr) | 2002-03-07 |
| US7566764B2 (en) | 2009-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02012743A (es) | Moleculas tipo il-17 y usos de las mismas. | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| MY150237A (en) | Cripto blocking antibodies and uses thereof | |
| DE60138715D1 (de) | Tnf-rezeptor-ähnliche moleküle und deren anwendungen | |
| CY1112957T1 (el) | Μη νευροτοξικοι παραγοντες, οι οποιοι ενεργοποιουν το πλασμινογονο για τη θεραπευτικη αγωγη εγκεφαλικου επεισοδιου | |
| MXPA03010079A (es) | Formulaciones de oxicodona de administracion una vez al dia. | |
| ATE532860T1 (de) | B7-ähnliche moleküle und deren anwendungen | |
| DE60235761D1 (de) | Isoform des vegfs | |
| BR9908823A (pt) | Compostos e processos para terapia e diagnóstico de câncer de pulmão | |
| DK1434791T3 (da) | Specifikke bindingsmidler til human angiopoietin-2 | |
| ATE368688T1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| GB0100551D0 (en) | Protein | |
| ATE417618T1 (de) | Faktor-viii-polypeptide auf hohem expressionsniveau codierende nukleinsäure- und aminosäuresequenzen und verwendungsverfahren | |
| ATE363531T1 (de) | Claudin polypeptide | |
| ATE549353T1 (de) | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen | |
| AUPP472398A0 (en) | Protease susceptibility II | |
| DE69931482D1 (de) | Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen | |
| WO2004076614A3 (de) | Humane nukleinsäuresequenzen aus prostatakarzinomen | |
| ATE323722T1 (de) | Antimikrobiell wirkendes peptid | |
| ATE328082T1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
| HUP0402327A2 (hu) | Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása | |
| FR2804127B1 (fr) | Gene srn1 implique dans le syndrome nephrotique cortico- resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques | |
| PL374550A1 (en) | Il-17 like molecules and uses thereof | |
| WO2001059120A3 (en) | Il-17 like molecules and uses thereof | |
| WO2003093305A3 (en) | Teneurin c-terminal associated peptides (tcap) and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| UEP | Publication of translation of european patent specification |
Ref document number: 1313855 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |